Nea Management Company, LLC Verona Pharma PLC Transaction History
Nea Management Company, LLC
- $1.4 Billion
- Q4 2024
A detailed history of Nea Management Company, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Nea Management Company, LLC holds 5,584,753 shares of VRNA stock, worth $373 Million. This represents 18.53% of its overall portfolio holdings.
Number of Shares
5,584,753
Previous 5,584,753
-0.0%
Holding current value
$373 Million
Previous $161 Million
61.42%
% of portfolio
18.53%
Previous 12.27%
Shares
5 transactions
Others Institutions Holding VRNA
# of Institutions
218Shares Held
67.5MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$427 Million9.9% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$226 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$209 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$209 Million2.81% of portfolio
-
Abingworth LLP London, X02.46MShares$164 Million21.3% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.07B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...